Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Birmex vs Sanofi OPV in Newborns
NCT01870206Phase 3Unknown
- Sponsor
- BIRMEX
- Start
- Jun 2013
- Primary completion
- Dec 2013
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of trivalent oral poliovirus vaccine in poliomyelitis, sponsored by BIRMEX. Status: unknown.
02
Drugs
trivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT01870206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01870206.